Evidence map›Paper›PMID 28331227›Full record

ArticleLeukemia2017

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.

A Dzikiewicz-Krawczyk, K Kok, I Slezak-Prochazka, J-L Robertus, J Bruining, M M Tayari, B Rutgers, D de Jong, J Koerts, A Seitz and 8 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma.Virchows Archiv : an international journal of pathology · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential.International journal of cardiology. Heart & vasculature · 2025
    Review
  10. Article
  11. Review
  12. S-acylation of CaChronic diseases and translational medicine · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

A Dzikiewicz-KrawczykDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
K KokDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
I Slezak-ProchazkaDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J-L RobertusDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J BruiningDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
M M TayariDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
B RutgersDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
D de JongDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J KoertsDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A SeitzDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J LiDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
B TillemaDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J E GuikemaDepartment of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
I M NolteDepartment of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A DiepstraDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
L VisserDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J KluiverDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A van den BergDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
University Medical Center Groningen · NLUniversity of Groningen · NLPolish Academy of Sciences · PLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genes, mybGenes, mycOncogenesAcyltransferasesBurkitt LymphomaCell Line, TumorGene Expression Regulation, NeoplasticHumansMicroRNAsAcyltransferasesMicroRNAsMIR150, humanZDHHC11B protein, humanZDHHC11 protein, human

Identifiers

PMID28331227
OpenAlexW2600165745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.